Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sight Sciences, Inc. Director's Dealing 2025

Dec 30, 2025

33763_dirs_2025-12-30_25327668-2c49-48d1-9ef6-548c99d9540e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: Sight Sciences, Inc. (SGHT)
CIK: 0001531177
Period of Report: 2022-09-21

Reporting Person: Badawi David (N/A)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-09-21 Stock Option (Right to Buy) $0.23 M 40000 Disposed 2026-02-28 Common Stock (40000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1448656 Direct

Footnotes

F1: Includes 1,441,196 shares that were previously reported as beneficially owned on the Reporting Person's Form 3 filed on July 14, 2021, as well as 7,460 shares that were acquired by the Reporting Person upon exercise of options prior to the Issuer's completion of the Initial Public Offering in July 2021 that should have been included under Column 2 of Table I of the Form 3 but were inadvertently included as shares underlying options with an exercise price of $0.23 that expire on February 28, 2026 under Column 3 of Table II of the Form 3.

F2: The grant of stock options ("Options") made to the Reporting Person vested and became exercisable as to 25% of the underlying shares on January 1, 2017, and as to the remainder of such shares in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date, such that all such Options shall be fully vested and exercisable on January 1, 2020.

F3: The original Form 4 filing identified the expiration date of the relevant Options as 01/08/2027. This amendment corrects the expiration date of the relevant Options to February 28, 2026.

F4: Excludes the 7,460 shares that were previously inadvertently included as described in footnote (1) to this Form 4.